Abstract
The elucidation of cross-talk events between intersecting signaling pathways is one main challenge in biological research. The complexity of protein networks, composed of different pathways, requires novel strategies and techniques to reveal relevant interrelations. Here, we established a combinatorial RNAi strategy for systematic single, double, and triple knockdown, and we measured the residual mRNAs and proteins quantitatively by quantitative real-time PCR and reverse-phase protein arrays, respectively, as a prerequisite for data analysis. Our results show that the parallel knockdown of at least three different genes is feasible while keeping both untargeted silencing and cytotoxicity low. The technique was validated by investigating the interplay of tyrosine kinase receptor ErbB2 and its downstream targets Akt-1 and MEK1 in cell invasion. This experimental approach combines multiple gene knockdown with a subsequent quantitative validation of reduced protein expression and is a major advancement toward the analysis of signaling pathways in systems biology.
MeSH Terms
Cell Line, Tumor
Combinatorial Chemistry Techniques
Humans
Proteins/analysis,genetics
RNA Interference
RNA, Small Interfering/genetics
Receptor Cross-Talk/physiology
Signal Transduction/physiology
Systems Biology
Chemicals
Proteins
RNA, Small Interfering
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Sahin Ozgür
Division of Molecular Genome Analysis, German Cancer Research Center, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
Löbke Christian
Korf Ulrike
Appelhans Heribert
Sültmann Holger
Poustka Annemarie
Wiemann Stefan
Arlt Dorit
References (15)
15 references, click to expand
-
Untangling the ErbB signalling network.
Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
PMID: 11252954
-
Infrared-based protein detection arrays for quantitative proteomics.
Proteomics. 2007 Feb;7(4):558-64
PMID: 17309101
-
Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1257-62
PMID: 14739340
-
Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells.
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1892-7
PMID: 14769924
-
Molecular basis for Rho GTPase signaling specificity.
Breast Cancer Res Treat. 2004 Mar;84(1):61-71
PMID: 14999155
-
Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference.
J Biol Chem. 2004 Apr 16;279(16):16657-61
PMID: 14985334
-
Insulin-like growth factors and neoplasia.
Nat Rev Cancer. 2004 Jul;4(7):505-18
PMID: 15229476
-
Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
Cancer. 1999 Aug 1;86(3):439-48
PMID: 10430252
-
The signaling network of tumor invasion.
Histol Histopathol. 2005 Apr;20(2):593-602
PMID: 15736063
-
Precision and variance components in quantitative gel electrophoresis.
Electrophoresis. 2005 Jun;26(12):2470-5
PMID: 15924365
-
Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.
RNA. 2006 Jul;12(7):1179-87
PMID: 16682560
-
Multiple shRNAs expressed by an inducible pol II promoter can knock down the expression of multiple target genes.
Biotechniques. 2006 Jul;41(1):64-8
PMID: 16869515
-
Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.
Cell Cycle. 2006 Aug;5(15):1654-61
PMID: 16861913
-
Integrin signaling in epithelial cells.
Cancer Lett. 2007 Mar 8;247(1):1-25
PMID: 16725254
-
ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
Cancer Res. 2001 Mar 1;61(5):1890-5
PMID: 11280743